Comparative Evaluation of Body Temperature Measurement Using the CardioWatch 287-2 in an Intensive Care Setting.

Launched by CORSANO HEALTH B.V. · Apr 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new device called the Corsano CardioWatch 287-2, which is a wristband that measures body temperature in a non-invasive way. Currently, many methods for checking temperature can be uncomfortable or expensive, and some are not continuous. The CardioWatch uses technology to track skin temperature and predict body temperature in real-time. Researchers want to see how accurately this wristband compares to the traditional method of taking temperature through the rectum, which is considered the gold standard in medical settings.

To participate in this trial, you need to be at least 18 years old and able to give your consent. Additionally, you must be a patient in the ICU or recovery room at the Reinier de Graaf hospital. However, if you have certain conditions, like skin issues that prevent you from wearing the wristband or if you have severe cognitive impairments, you may not be eligible. If you join the study, you'll help researchers understand if this new device can be a reliable way to monitor body temperature, which could improve care for patients in the ICU. Remember, the trial is not yet recruiting participants, so more information will be available once it starts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥ 18 years old;
• • Able to provide consent
• • Administered at the ICU or recovery room of the Reinier de Graaf hospita
• Exclusion Criteria:
• • Unable to wear the Corsano CardioWatch 287 or Radius-T sensor due to reasons such as allergic reactions, wounds, amputations etc.;
• • Unable to receive rectal temperature monitoring;
• • Thermoregulatory problems or diseases;
• • Hyperthermia (\>40°C);
• • Known allergy to plastics / latex;
• • Patient not willing to sign informed consent;
• • Significant mental or cognitive impairment.